Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01815372
Other study ID # SPEDI
Secondary ID
Status Completed
Phase N/A
First received November 26, 2012
Last updated November 5, 2013
Start date October 2012
Est. completion date June 2013

Study information

Verified date November 2013
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research Ethics
Study type Interventional

Clinical Trial Summary

Background and aims: Ultrasound-guided (USG) nerve blocks of the sciatic nerve (popliteal level = PL) and the saphenous nerve (mid-femoral level = MFL) provides analgesia following leg surgery. Traditionally two separate injections are performed. The aim was to describe a novel, faster USG block combination requiring only one skin penetration to block the sciatic and saphenous nerves; i.e. the SPEDI block = Single PEnetration Dual Injection.

Methods: A randomized, controlled and double-blinded trial. Following ethics committee approval 60 patients will be randomized to the administration of an USG SPEDI block compared to two separate USG blocks of the saphenous (MFL) and sciatic (PL) nerves. Blocks will be performed after induction of general anaesthesia. Outcome measures will be performance time (primary outcome measure), Post-Anaesthesia Care Unit pain scores (VAS scores 0-10), block difficulty level (easy, middle, difficult), opioid consumption (in the PACU), serum-ropivacaine pharmacokinetics (blood sample 0-180 minutes). Both block combinations will be evaluated by MR imaging (MRI).

Hypothesis: The USG SPEDI block combination is expected to be performed significantly faster without moving the leg, and achieve successful perioperative pain management. The SPEDI block may find important use in the emergency setting.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date June 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- lower leg surgery

- American Society of Anesthesiologist (ASA) score I-III

- Can cooperate in the study

- Speaks and understand the Danish language

- General anesthesia

Exclusion Criteria:

- Intake of oral morphine above 40 mg per day

- Know allergy to ropivacaine

- Abuse of alcohol or other substance abuse

- Neuropathy

- Pregnant

- Nerve block contraindicated

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Single penetration dual injection (SPEDI) block technique to block the sciatic and the saphenous nerve with one needle penetration of the skin

The classical popliteal sciatic nerve block combined with the mid-femoral saphenous nerve block


Locations

Country Name City State
Denmark Bispebjerg Hospital Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Opioid consumption (micrograms of sufentanil) in total in the recovery unit. Normally from 0 hours until 2 hours after arrival in the recovery unit. No
Primary Performance time (seconds and minutes). Time measurement from the time the ultrasound transducer is placed on the skin and until the needle is taken out of the body. The time measurement is done with a normal clock - measuring seconds and minutes. The measurement (seconds and minutes) will take place in the operating room. This will normally be within a time frame of 1 minute to 10 minutes. No
Secondary Pain score (VAS score 0-10). When the patient are evaluated in the recovery unit upon arrival and when the patient is discharged from the recovery unit. This means from time 0 hours (arrival in the PACU) and normally until 2 hours after arrival in the PACU. No
Secondary Sensory dermatome testing. Sensory dermatome testing is done with cold ethanol on skin test. All dermatomes on the leg and foot are tested, and there is a comparison of the outcome between the operated leg and the not-operated leg. Normally until 2 hours postoperatively. No